GLOBAL IMMUNOHISTOCHEMISTRY MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

GLOBAL IMMUNOHISTOCHEMISTRY MARKET 2019-2027

Market By Products, Applications, End-users And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The global immunohistochemistry market is expected to display an upward trend in terms of revenue by exhibiting a CAGR of 7.11% over the forecast period of 2019-2027. The market was assessed to be worth $1727 million in the year 2018 and is predicted to generate a revenue of approximately $3225 million by the year 2027.

Immunohistochemistry (IHC) is the process that involves selectively imaging antigens (proteins) in the cells of a tissue section by the exploitation of the principle of antibodies that bind particularly to antigens in biological tissues. IHC derives its name from the word "immuno," that refers to antibodies used in the procedure. The term "histo" stands for tissue.

Report scope can be customized per your requirements. Request For Customization

Immunohistochemical staining is extensively used for diagnosing abnormal cells like those found in cancerous tumors. Specific molecular markers are a characteristic attribute of specific cellular events like the proliferation or cell death (apoptosis). IHC is also used extensively in general research to understand the localization and distribution of biomarkers and differential expression proteins in various parts of biological tissue.

Traditionally, immunodetectors use the 3 step biotin-streptavidin-enzyme technique. However, novel technological enhancements have helped to develop the polydetectors and cytodetectors kits that implement tandem hyperlabelling technology to directly label immunoglobulins with enzymes, thus resulting in reproducible and consistent immunostaining for all types of nuclear, cytoplasmic and membranal antigens in various types of cells or tissues.

In 2016, North America accounted for the highest revenue share in the global market, mainly due to factors such as the rising incidences of chronic diseases, matured biotechnology industry, the rising commercialization of the immunohistochemistry products and developed research & healthcare institutions. Within this report, the history of immunochemistry and key insights regarding the industry have been discussed in detail. Also, the market attractiveness matrix, regulatory outlook and the value chain outlook have been studied for the immunohistochemistry industry. 

Market drivers like the in-vitro technological advancements, an increase in the cancer cases, the increasing healthcare spending, the rise in the geriatric population and the growing use of POC testing have been thoroughly analyzed. The industry is facing restraints like restriction of systems and reimbursement issues which are obstructing the industry growth. Key opportunities like the increasing use of biomarkers for disease diagnosis and technological advancements can be leveraged by the industry to get towards the projected growth.

Challenges such as the stringent regulations and high maintenance costs which are influencing the market growth are being faced by this industry presently.

To get detailed insights on segments, Download Sample Report

Geographies covered in the global immunohistochemistry market:

•    North America: the United States and Canada

•    Europe: the United Kingdom, Germany, France, Italy, Spain, Russia and rest of Europe

•    Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and rest of Asia-Pacific

•    Latin America: Brazil, Mexico, Argentina, Chile, Cuba and rest of Latin America

•    The Middle East & Africa: the United Arab Emirates, Turkey, Saudi Arabia, South Africa and rest of the Middle East & Africa

The immunohistochemistry market has been segmented into:

•    By products:

o    Antibodies

•    Primary antibodies

•    Secondary antibodies

o    Equipment

•    Slide staining systems

•    Tissue microarrays

•    Tissue processing systems

•    Slide scanners

•    Other equipment

o    Reagents

•    Histological stains

•    Blocking sera and reagents

•    Chromogenic substrates

•    Fixation reagents

•    Stabilizers

•    Organic Solvents

•    Proteolytic Enzymes

•    Diluents

o    Kits

•    By applications:

o    Diagnostics

•    Cancer

•    Infectious disease

•    Cardiovascular disease

•    Autoimmune diseases

•    Diabetes mellitus

•    Nephrological diseases

o    Drug testing

•    By end-users: 

o    Hospitals and diagnostic laboratories

o    Research institutes

o    Other end-users


The key players in the immunohistochemistry market include Cell Signaling Technology, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., HistologiX, BioGenex, Bio SB, Abcam Plc, PerkinElmer, Inc., Danaher Corporation, Siemens AG Healthcare, Agilent Technologies, Inc., F. Hoffmann-La Roche AG and Abbott Laboratories.

The strategic analysis for each of these companies in the immunohistochemistry market has been covered in detail. The players in this industry are undergoing mergers & acquisitions to address the increasing pace and level of competition worldwide. The company market share helps to dive into the information about the key market players in this industry and how much hold they have on the market. 


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    IMMUNOHISTOCHEMISTRY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. HISTORY OF IMMUNOHISTOCHEMISTRY

2.3. VALUE CHAIN OUTLOOK

2.4. KEY INSIGHTS

2.5. REGULATORY OUTLOOK

2.5.1.   REGULATIONS IN THE UNITED STATES

2.6. MARKET ATTRACTIVENESS MATRIX

2.7. MARKET DRIVERS

2.7.1.   IN-VITRO TECHNOLOGICAL ADVANCEMENTS

2.7.2.   INCREASING CANCER OCCURRENCE

2.7.3.   SWELLING HEALTHCARE SPENDING

2.7.4.   RISING GERIATRIC POPULATION

2.7.5.   INCREASING USE OF POC TESTING

2.8. MARKET RESTRAINTS

2.8.1.   RESTRICTIONS OF CLOSED SYSTEMS

2.8.2.   REIMBURSEMENT ISSUES

2.9. MARKET OPPORTUNITIES

2.9.1.   INCREASING USE OF BIOMARKERS FOR DISEASE DIAGNOSIS

2.9.2.   TECHNOLOGICAL ADVANCEMENTS

2.10.            MARKET CHALLENGES

2.10.1.                STRINGENT REGULATIONS

2.10.2.                HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH

3.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS

3.1. ANTIBODIES

3.1.1.   PRIMARY ANTIBODIES

3.1.2.   SECONDARY ANTIBODIES

3.2. EQUIPMENT

3.2.1.   SLIDE STAINING SYSTEMS

3.2.2.   TISSUE MICROARRAYS

3.2.3.   TISSUE PROCESSING SYSTEMS

3.2.4.   SLIDE SCANNERS

3.2.5.   OTHER EQUIPMENT

3.3. REAGENTS

3.3.1.   HISTOLOGICAL STAINS

3.3.2.   BLOCKING SERA AND REAGENTS

3.3.3.   CHROMOGENIC SUBSTRATES

3.3.4.   FIXATION REAGENTS

3.3.5.   STABILIZERS

3.3.6.   ORGANIC SOLVENTS

3.3.7.   PROTEOLYTIC ENZYMES

3.3.8.   DILUENTS

3.4. KITS

4.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS

4.1. DIAGNOSTICS

4.1.1.   CANCER

4.1.2.   INFECTIOUS DISEASES

4.1.3.   CARDIOVASCULAR DISEASE

4.1.4.   AUTOIMMUNE DISEASES

4.1.5.   DIABETES MELLITUS

4.1.6.   NEPHROLOGICAL DISEASES

4.2. DRUG TESTING

5.    IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS

5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES

5.2. RESEARCH INSTITUTES

5.3. OTHER END-USERS

6.    IMMUNOHISTOCHEMISTRY (IHC) MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY PRODUCTS

6.1.2.   MARKET BY APPLICATIONS

6.1.3.   MARKET BY END-USERS

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      THE UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY PRODUCTS

6.2.2.   MARKET BY APPLICATIONS

6.2.3.   MARKET BY END-USERS

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      THE UNITED KINGDOM

6.2.4.2.      FRANCE

6.2.4.3.      GERMANY

6.2.4.4.      SPAIN

6.2.4.5.      ITALY

6.2.4.6.      RUSSIA

6.2.4.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY PRODUCTS

6.3.2.   MARKET BY APPLICATIONS

6.3.3.   MARKET BY END-USERS

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      CHINA

6.3.4.2.      INDIA

6.3.4.3.      JAPAN

6.3.4.4.      SOUTH KOREA

6.3.4.5.      AUSTRALIA & NEW ZEALAND

6.3.4.6.      ASEAN COUNTRIES

6.3.4.7.      REST OF APAC

6.4. LATIN AMERICA

6.4.1.   MARKET BY PRODUCTS

6.4.2.   MARKET BY APPLICATIONS

6.4.3.   MARKET BY END-USERS

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      ARGENTINA

6.4.4.4.      CHILE

6.4.4.5.      CUBA

6.4.4.6.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY PRODUCTS

6.5.2.   MARKET BY APPLICATIONS

6.5.3.   MARKET BY END-USERS

6.5.4.   COUNTRY ANALYSIS

6.5.4.1.      SAUDI ARABIA

6.5.4.2.      TURKEY

6.5.4.3.      UNITED ARAB EMIRATES

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST AND AFRICA

7.    COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ABCAM PLC

7.3. AGILENT TECHNOLOGIES, INC.

7.4. BIOGENEX

7.5. BIO-RAD LABORATORIES, INC.

7.6. BIO SB

7.7. CELL SIGNALING TECHNOLOGY, INC.

7.8. DANAHER CORPORATION

7.9. F. HOFFMANN-LA ROCHE AG

7.10.            HISTOLOGIX

7.11.            MERCK MILLIPORE

7.12.            PERKINELMER, INC.

7.13.            SIEMENS AG HEALTHCARE

7.14.            THERMO FISHER SCIENTIFIC, INC.

8.    METHODOLOGY AND SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        GLOBAL MARKET FOR IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)

TABLE 2        ANTIBODY MANUFACTURERS IN THE GLOBAL IMMUNOHISTOCHEMISTRY MARKET

TABLE 3        CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT

TABLE 4        POPULATION AGED 60 YEARS AND ABOVE

TABLE 5        POPULATION AGED 80 YEARS AND ABOVE

TABLE 6        COUNTRIES WITH THE HIGHEST NUMBER OF ELDERLY PEOPLE

TABLE 7        GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 8        INCIDENCE OF DIABETES IN MAJOR COUNTRIES 2016 ($ MILLION)

TABLE 9        CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES

TABLE 10      SECONDARY ANTIBODY SELECTION

TABLE 11      GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)

TABLE 12      HEALTHCARE SPENDING BY HIGH-INCOME COUNTRIES BY 2040

TABLE 13      GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)

TABLE 14      HISTOLOGY STAINS AND ITS CATEGORIES

TABLE 15      COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS

TABLE 16      KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION

TABLE 17      GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 18      GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)

TABLE 19      SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES

TABLE 20      GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 21      CANCER RESEARCH PROGRAM

TABLE 22      IMMUNOHISTOCHEMISTRY USAGE IN FORENSIC PATHOLOGY

TABLE 23      GLOBAL IMMUNOHISTOCHEMISTRY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 24      NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 25      NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 26      NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 27      NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 28      FUNDS INVESTED FOR DIFFERENT CANCER TYPES (2017)

TABLE 29      PERCENT DISTRIBUTION OF PROJECTED NEW CANCER CASES (2017)

TABLE 30      EUROPE IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 31      EUROPE IMMUNOHISTOCHEMISTRY MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 32      EUROPE IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 33      EUROPE IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 34      NUMBER OF PEOPLE LIVING AND DYING WITH CVD

TABLE 35      NUMBER OF DEATHS CAUSED BY CARDIOVASCULAR DISEASES IN GERMANY 2016

TABLE 36      DISEASES CAUSING PREMATURE DEATH IN GERMANY (2017)

TABLE 37      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 38      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 39      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 40      ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 41      CANCER TYPES BASED ON INCIDENCE RATES (2016)

TABLE 42      CANCER TYPES BASED ON MORTALITY RATES (2016)

TABLE 43      ESTIMATED INCIDENCE OF ALL CANCERS COMBINED BY SEX (2017)

TABLE 44      ESTIMATED COMMON CAUSES OF DEATH FOR CANCER (MALES 2017)

TABLE 45      ESTIMATED COMMON CAUSES OF DEATH FOR CANCER (FEMALES 2017)

TABLE 46      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

TABLE 47      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 48      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 49      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 50      LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 51      CAUSES OF DEATH IN ARGENTINA 2016

TABLE 52      CAUSES OF DEATH IN CUBA 2016

TABLE 53      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 54      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 55      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 56      MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURE 1      GLOBAL MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)

FIGURE 2      HISTORY OF IMMUNOHISTOCHEMISTRY

FIGURE 3      GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL ANTIBODIES MARKET IN PRIMARY ANTIBODIES BY REGION 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL ANTIBODIES MARKET IN SECONDARY ANTIBODIES REGION 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS BY REGION 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL EQUIPMENT MARKET IN TISSUE MICROARRAYS BY REGION 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS BY REGION 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL EQUIPMENT MARKET IN SLIDE SCANNERS BY REGION 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL EQUIPMENT MARKET IN OTHER EQUIPMENT BY REGION 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL REAGENTS MARKET IN HISTOLOGICAL STAINS BY REGION 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL REAGENTS MARKET IN BLOCKING SERA AND REAGENTS BY REGION 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL REAGENTS MARKET IN CHROMOGENIC SUBSTRATES BY REGION 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL REAGENTS MARKET IN FIXATION REAGENTS BY REGION 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL REAGENTS MARKET IN STABILIZERS BY REGION 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL REAGENTS MARKET IN ORGANIC SOLVENTS BY REGION 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL REAGENTS MARKET IN PROTEOLYTIC ENZYMES BY REGION 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL REAGENTS MARKET IN DILUENTS BY REGION 2019-2027 ($ MILLION)

FIGURE 21   PHASES OF HISTOLOGICAL STAINING

FIGURE 22   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL DIAGNOSTICS MARKET IN CANCER BY REGION 2019-2027 ($ MILLION)

FIGURE 25   DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE BY REGION 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES BY REGION 2019-2027 ($ MILLION)

FIGURE 27   GLOBAL DIAGNOSTICS MARKET IN DIABETES MELLITUS BY REGION 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES BY REGION 2019-2027 ($ MILLION)

FIGURE 29   HEALTHCARE EXPENDITURES ACROSS THE GLOBE (% OF GDP)

FIGURE 30   GLOBAL PREVALENCE OF CHRONIC KIDNEY DISEASES BY AGE

FIGURE 31   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)

FIGURE 32   INCIDENCE OF PATIENTS WITH CHRONIC DISEASES GLOBALLY 2005-2030

FIGURE 33   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)

FIGURE 34   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)

FIGURE 35   GLOBAL IMMUNOHISTOCHEMISTRY MARKET IN OTHER END-USERS 2019-2027 ($ MILLION)

FIGURE 36   NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 37   THE UNITED STATES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 38   CANADA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 39   EUROPE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 40   THE UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 41   FRANCE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 42   GERMANY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 43   SPAIN IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 44   ITALY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 45   RUSSIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 46   REST OF EUROPE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 47   ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 48   CHINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 49   INDIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 50   JAPAN IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 51   SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 52   AUSTRALIA & NEW ZEALAND IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 53   ASEAN COUNTRIES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 54   REST OF APAC IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 55   LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 56   BRAZIL IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 57   HEALTHCARE SPENDING IN MEXICO 2014 AND 2040 ($ BILLION)

FIGURE 58   MEXICO IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 59   HEALTHCARE SPENDING IN ARGENTINA 2014 AND 2040 ($ BILLION

FIGURE 60   ARGENTINA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 61   CHILE IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 62   HEALTHCARE EXPENDITURE IN CHILE 2005-2016 (PERCENTAGE SHARE OF GDP)

FIGURE 63   HEALTHCARE SPENDING IN CUBA (2014 AND 2040)

FIGURE 64   CUBA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 65   REST OF LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 66   MIDDLE EAST AND NORTH AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 67   SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 68   TURKEY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 69   UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 70   SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

FIGURE 71   REST OF MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;